SCHEMBL13133759

SCHEMBL13133759

c1ccc(-c2ccc(N(c3ccc(-c4cn5ccccc5n4)cc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 10/20 0.49
▸ NPC1 O15118 9/20 0.49
▸ KDM4E B2RXH2 7/20 0.49
▸ POLB P06746 1/20 0.49
▸ GFER P55789 3/20 0.48
▸ ALDH1A1 P00352 6/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ PKM P14618 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ EPHX2 P34913 1/20 0.46
▸ ALDH1A3 P47895 4/20 0.46
▸ ALDH1A2 O94788 1/20 0.46
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2813623 0.97 RAB9A (0.50) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133736 0.94 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133738 0.94 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133743 0.93 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133763 0.92 ALDH1A3 (0.48) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13043653 0.91 RAB9A (0.58) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133733 0.91 RAB9A (0.45) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133750 0.90 RAB9A (0.46) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL2812399 0.89 RAB9A (0.45) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133732 0.89 RAB9A (0.46) RAB9ANPC1KDM4EPOLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853403-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-07 — — US disclosed
US-8853403-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-07 — — US disclosed
US-20130130061-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-05-23 — — US disclosed
US-20130130061-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-05-23 — — US disclosed
US-8329917-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-12-11 — — US disclosed
US-8329917-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-12-11 — — US disclosed
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-09-30 — — US disclosed
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same CRY1, LAGE3, NR2E3 RAB9A 1570/4885NPC1 4412/4885KDM4E 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback